Pharmaceutical Crystals (Record no. 69488)

MARC details
000 -LEADER
fixed length control field 04249naaaa2200925uu 4500
001 - CONTROL NUMBER
control field https://directory.doabooks.org/handle/20.500.12854/56130
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220220060311.0
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number books978-3-03928-713-0
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783039287123
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783039287130
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.3390/books978-3-03928-713-0
Terms of availability doi
041 0# - LANGUAGE CODE
Language code of text/sound track or separate title English
042 ## - AUTHENTICATION CODE
Authentication code dc
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Uekusa, Hidehiro
Relationship auth
245 10 - TITLE STATEMENT
Title Pharmaceutical Crystals
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. MDPI - Multidisciplinary Digital Publishing Institute
Date of publication, distribution, etc. 2020
300 ## - PHYSICAL DESCRIPTION
Extent 1 electronic resource (148 p.)
506 0# - RESTRICTIONS ON ACCESS NOTE
Terms governing access Open Access
Source of term star
Standardized terminology for access restriction Unrestricted online access
520 ## - SUMMARY, ETC.
Summary, etc. The crystalline state is the most commonly used essential solid active pharmaceutical ingredient (API). The characterization of pharmaceutical crystals encompasses many scientific disciplines, but the core is crystal structure analysis, which reveals the molecular structure of essential pharmaceutical compounds. Crystal structure analysis provides important structural information related to the API's wide range of physicochemical properties, such as solubility, stability, tablet performance, color, and hygroscopicity. This book entitled “Pharmaceutical Crystals"" focuses on the relationship between crystal structure and physicochemical properties. In particular, the new crystal structure of pharmaceutical compounds involving multi-component crystals, such as co-crystals, salts, and hydrates, and polymorph crystals are reported. Such crystal structures were investigated in the latest studies that combined morphology, spectroscopic, theoretical calculation, and thermal analysis with crystallographic study. This book highlights the importance of crystal structure information in many areas of pharmaceutical science and presents current trends in the structure–property study of pharmaceutical crystals. The Guest Editors of this book hope the readers enjoy a wide variety of recent studies on Pharmaceutical Crystals.
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE
Terms governing use and reproduction Creative Commons
Use and reproduction rights https://creativecommons.org/licenses/by-nc-nd/4.0/
Source of term cc
-- https://creativecommons.org/licenses/by-nc-nd/4.0/
546 ## - LANGUAGE NOTE
Language note English
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term crystal structure analysis
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term n/a
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term famotidine
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term solution crystallization
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term salt optimization
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term structure determination from powder diffraction data
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Hirshfeld surface analysis
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term DFT
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term molecular docking study
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term melting diagram
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term dehydration
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term hygroscopicity
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term HBV
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Benzodioxole
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term pharmaceutical crystals
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term 4-b]indol-4-one
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term pyrimidin-4(3H)-one
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term liquid assisted grinding
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term HOMO-LUMO
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term dissolution
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term cocrystal formation
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Raman spectroscopy
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term carbamazepine
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term hydrogen bonding
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term 3
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term ondansetron
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term physicochemical properties
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term solubility
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term succinic acid
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term cocrystal
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term adefovir dipivoxil
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term hepatitis B
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term polymorphs
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term hydrogen-bond-acceptance ability
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term DFT study
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Nitrofurantoin–4-dimethylaminopyridine (NF-DMAP) salt
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term photostability
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term on-line monitoring
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term 5-dihydro-4H-pyrimido[5
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Imidazole
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Semicarbazone
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term crystal habit
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Crystal structure
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term solvent-mediated polymorphic transformation
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term ticagrelor
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term hydrate
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term pharmaceutical cocrystal
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term malonic acid
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term 1H-indole
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term reactivity descriptors
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term famoxadone
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term crystal structure
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term dicarboxylic acid
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term hydrogen bond
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term saccharin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Yonemochi, Etsuo
Relationship auth
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://mdpi.com/books/pdfview/book/2162">https://mdpi.com/books/pdfview/book/2162</a>
Access status 0
Public note DOAB: download the publication
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://directory.doabooks.org/handle/20.500.12854/56130">https://directory.doabooks.org/handle/20.500.12854/56130</a>
Access status 0
Public note DOAB: description of the publication

No items available.